성요한초제제 임상시험 고찰을 통한 한약기원 항우울제 임상시험 방법론 연구
A Study on the Methodology for a Clinical Trial of an Antidepressive Korean Herb by Comparison with St. John's Wort Trials
0
조회
0
다운로드
3
인용
0
참고문헌
초록
Abstract
Objectives : This study was undertaken to learn what should be considered in a good clinical trial investigating a herbal medicine as an antidepressant. Methods : Five well-designed clinical trials published from 2000 to 2006 investigating SJWE in depressive disorder were selected. The trials were reviewed and compared in terms of methodology such as trial design, patient selection, efficacy & safety evaluation, and so on. On the basis of this review of the trials and the regulations and guidelines of KFDA, we suggest some points to be considered for a good clinical trial of a herb for depression. Results : Although every trial had its own unique design, procedure, objectives and so on, all trials used randomizing and double blinding methods. If there is no ethical problem, a placebo-controlled design should be considered in a herbal antidepressant clinical trial for depression. Conclusions : Some points to be considered in an optimal & good clinical trial for an antidepressive herbal medicine were suggested as follows: 1) randomizing and double blinding manner is essential, 2) if there is no ethical problem, placebo control design should be considered, 3) the trial period should be 6 weeks, 4) out-patients will be recruited as subjects, 5) investigators will be well-trained psychiatrists or medical doctors, 6) the number of subjects should be calculated by statistical methods, 7) subjects should be diagnosed by DSM-Ⅳcriteria, 8) subjects who have current risk of committing suicide should be excluded, etc.
참고문헌 (29)
- "Safety and efficacy of Korean medicine and therapeutics", 24(3), pp.531~542 (2003)
- "Evidence-based health policy: lessons from the global burden of disease study", 274, pp.740~743 (1996)
- "Pharmacogenomics and antidepressant drugs", 38, pp.82~94 (2006)
- "Society for promoting Christian Knowledge" (1853)
- "chronological history of plants" (1879)
- "Efficacy of St. John's Wort extract WS 5570 in major depression: A double-blind, placebo- controlled trial", 159, pp.1361~1366 (2002)
- "John's Wort for depression-an overview and meta-analysis of randomised clinical trials", 313, pp.253~258 (1996)
- "Hypericum extrat LI 160 fluoxetine in mild to moderate depression", 255, pp.40~47 (2005)
- "Treatment of depressive symptoms with a high concentration hypericum preparation: A multicenter placebo-controlled double-blind study", 113, pp.404~408 (1995)
- "Resources of the Southern Fields and Forests Prepared and Published by oerder of the Surgeon-General", eco(mical), Arno Press
- "Behandlung leichter bis Mittelschwerer Depressionen", 7, pp.235~240 (1993)
- "Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline", pp.1~ (1994), A multicenter double-blind study
- "Efficacy and tolerability of St. John's Wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10", 30(2), pp.81~85 (1997)
- "LI 160, an extract of St. John's Wort, versus amitriptyline in mildly to moderately depressed outpatients-a controlled 6-week clinical trial", 30(2), pp.77~80 (1997)
- "Multicenter double-blind study examining the antidepressant effectiveness of the hypericum extract LI 160", pp.1~ (1994)
- "Neuropharmacology of St. John's wort (hypericum)", 32, pp.1202~1208 (1998)
- "The efficacy of St. John's Wort in patients with minor depressive symptoms or dusthmia - a double-blind placebo-controlled study", 13, pp.215~221 (2006)
- "Comparison of an extract of Hypericum (LI 160) and Sertraline in the treatment of depression: A double-blind, randomized pilot study", 22(4), pp.411~419 (2000)
- "Comparisom of St John's Wort and imipramine for treating depression: randomised controlled trial", 321(7260), pp.536~539 (2000)
- "Diagnostic and statistical manual of mental disorders" (1994), American Psychiatric Association
- "Development of a rating scale for primary depressive illness", 6, pp.278~296 (1967)
- "An inventory for measuring depression", pp.561~571 (1961)
- "A techique for the measurement of attitudes" (1932)
- "Handbuch psychologischer und pdagogischer Tests" (1975)
- "ECDEU Assessment Manual for Psychopharmacology US Department of Health", pp.76~338 (1976)
- "A new depression scale designed to be sensitive to change", pp.382~389 (1979)
- "Quantitative rating of depressive states", pp.161~170
- "Adverse Reactions Terminology (WHO-ART)" (1999), World Health Organisation
- "Concept paper on the revision of the committee for proprietary medicinal products (CPMP) note for guidance on medicinal products for the treatment of depression" (1998), EMEA